ZyVersa to Showcase Breakthrough Kidney Disease Drug at JPM Healthcare Conference 2025
ZyVersa Therapeutics (NASDAQ: ZVSA) announces CEO Stephen C. Glover's attendance at JPM's 43rd Annual Healthcare...
ZyVersa Therapeutics (NASDAQ: ZVSA) announces CEO Stephen C. Glover's attendance at JPM's 43rd Annual Healthcare...
This pioneering research focuses on identifying specific protein markers in senescent cells—aged cells that stop dividing but don’t die—offering new...
First patients treated with noninvasive ultrasound therapy October 16, 2024 The UCI Health interventional radiologist Dr....